Your browser doesn't support javascript.
loading
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Albiges, Laurence; Gurney, Howard; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Lee, Jae Lyun; Stus, Viktor; Ferguson, Thomas; Wiechno, Pawel; Gokmen, Erhan; Lacombe, Louis; Gedye, Craig; Perini, Rodolfo F; Sharma, Manish; Peng, Xiang; Lee, Chung-Han.
Afiliação
  • Albiges L; Gustave Roussy, Paris-Saclay University, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr.
  • Gurney H; Macquarie University, Sydney, NSW, Australia.
  • Atduev V; Volga District Medical Center, Federal Medical-Biological Agency, Nizhny Novgorod, Russia.
  • Suarez C; Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Climent MA; Instituto Valenciano de Oncología, Valencia, Spain.
  • Pook D; School of Clinical Sciences, Monash Health, Melbourne, VIC, Australia.
  • Tomczak P; Poznan University of Medical Sciences, Poznan, Poland.
  • Barthelemy P; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
  • Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Stus V; Dnipro State Medical University, Dnipro, Ukraine.
  • Ferguson T; Fiona Stanley Hospital, Perth, WA, Australia.
  • Wiechno P; Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland.
  • Gokmen E; Ege University Medical Faculty, Izmir, Türkiye.
  • Lacombe L; Centre de Recherche du CHU de Québec, Québec City, QC, Canada.
  • Gedye C; Department of Medical Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia.
  • Perini RF; Merck & Co, Rahway, NJ, USA.
  • Sharma M; Merck & Co, Rahway, NJ, USA.
  • Peng X; Merck & Co, Rahway, NJ, USA.
  • Lee CH; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lancet Oncol ; 24(8): 881-891, 2023 08.
Article em En | MEDLINE | ID: mdl-37451291
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article